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Abstract
Background: Spirometry via telehealth (telespirometry) involves remote monitoring of lung function, which
is useful to detect pulmonary changes and increase continuity of care for patients with cystic fibrosis
(CF). Purpose: This systematic review aims to evaluate the feasibility and efficacy of telespirometry
assessments for paediatric and adult CF patients. Method: A comprehensive search of health-related
databases (CINAHL, Emcare (Ovid), Medline (Ovid), PEDRo and Scopus) was conducted. For inclusion,
patients had to be clinically diagnosed with CF and studies could be of any study design or level according
to the National Health and Medical Research Council (NHMRC) evidence hierarchy, had to use
telespirometry devices for lung function tests, and be written or translated into English. The Crowe
Critical Appraisal Tool (CCAT) was used to assess study quality, while also accounting for potential
sources of bias encountered during the review process. Data was exported and summarised using the
population, intervention, comparators, and outcomes (PICO) framework in Microsoft excel, to provide
clinical recommendations. Results: Fourteen studies were included, with participants ranging from 5
to 44-years-old. Thirteen trials were performed domestically, while sample sizes and baseline patient
characteristics varied. Nine studies analysed a control and intervention group. All studies varied in the
intervention regime and clinical support provided. Collectively, the literature indicated poor patient
adherence to telespirometry, which acted as a barrier to gauging its efficacy. Although appearing to be
effective in detecting pulmonary deterioration, inconsistencies in pulmonary exacerbation (PEx) criteria
were identified and lack of significant improvements in pulmonary outcomes were observed. Conclusion:
Poor quality literature and small sample sizes increased risk of bias and restricted the application of
the results to clinical practice. The current evidence base is limited by minimal experimental studies,
lack of standardised telespirometry protocols, and criteria for PExs and poor patient compliance.
Recommendations: At this stage, telespirometry for CF monitoring should be used by motivated and
rurally/remotely located patients to complement in-person consults until its uptake is improved and
accuracy and clinically efficacy can be ascertained.
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ABSTRACT
Background: Spirometry via telehealth (telespirometry) involves remote monitoring of lung function, which is useful to detect
pulmonary changes and increase continuity of care for patients with cystic fibrosis (CF). Purpose: This systematic review aims to
evaluate the feasibility and efficacy of telespirometry assessments for paediatric and adult CF patients. Method: A comprehensive
search of health-related databases (CINAHL, Emcare (Ovid), Medline (Ovid), PEDRo and Scopus) was conducted. For inclusion,
patients had to be clinically diagnosed with CF and studies could be of any study design or level according to the National Health
and Medical Research Council (NHMRC) evidence hierarchy, had to use telespirometry devices for lung function tests, and be
written or translated into English. The Crowe Critical Appraisal Tool (CCAT) was used to assess study quality, while also accounting
for potential sources of bias encountered during the review process. Data was exported and summarised using the population,
intervention, comparators, and outcomes (PICO) framework in Microsoft excel, to provide clinical recommendations. Results:
Fourteen studies were included, with participants ranging from 5 to 44-years-old. Thirteen trials were performed domestically, while
sample sizes and baseline patient characteristics varied. Nine studies analysed a control and intervention group. All studies varied
in the intervention regime and clinical support provided. Collectively, the literature indicated poor patient adherence to
telespirometry, which acted as a barrier to gauging its efficacy. Although appearing to be effective in detecting pulmonary
deterioration, inconsistencies in pulmonary exacerbation (PEx) criteria were identified and lack of significant improvements in
pulmonary outcomes were observed. Conclusion: Poor quality literature and small sample sizes increased risk of bias and
restricted the application of the results to clinical practice. The current evidence base is limited by minimal experimental studies,
lack of standardised telespirometry protocols, and criteria for PExs and poor patient compliance. Recommendations: At this stage,
telespirometry for CF monitoring should be used by motivated and rurally/remotely located patients to complement in-person
consults until its uptake is improved and accuracy and clinically efficacy can be ascertained.
Keywords: telehealth, spirometry, pulmonary function
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INTRODUCTION
Cystic fibrosis (CF) is an inherited chronic disease caused by an autosomal recessive mutation of the cystic fibrosis transmembrane
regulator (CFTR) gene, responsible for coding the CFTR protein. Dysfunction of this protein results in the accumulation of thick,
highly concentrated mucus causing harmful blockages in organs such as the lungs, liver, pancreas, and intestines.1 Within the
respiratory system, these altered secretions can harbour bacteria, increasing the frequency of respiratory infection and subsequent
pulmonary exacerbations (PExs). The progressive nature of CF unfortunately means this respiratory dysfunction is cyclic and
damage to the airways is irreversible, resulting in bronchiectactic-like changes which inhibit mucociliary clearance and further
increase infection risk. Pulmonary decline combined with other pathological organ changes limit the life expectancy of those with
CF and diminish aspects such as quality of life (QoL).2
Health professionals (HPs) provide ongoing assessments and treatments often in specialised CF centres.3 As there are currently
no curative treatments for CF, close monitoring of signs and symptoms alongside therapies such as airway clearance techniques,
ventilation, exercise, antibiotic treatment, and nutritional intervention are used to optimise patient outcomes.4 Physiotherapy has a
key role in CF care, providing interventions such as airway clearance techniques and exercise prescription and undertaking
spirometry as a pulmonary function test (PFT). Spirometry is an essential tool for monitoring different aspects of lung function,
which include anticipating and assessing responses to interventions, determining patient prognoses, and predicting PExs.
Moreover, the readings can often change before the presentation of clinical symptoms, preventing avoidable hospitalisations.5
Changes particularly in FEV1 are used to assist in the diagnosis of a PEx, which is usually indicated by a decrease of more than
10% from baseline.5, 6
Telehealth is a promising emerging health care platform. Through the use of information communication technologies (ICT), health
services usually offered in-person can be delivered remotely to diagnose, assess, and treat acute and chronic conditions.7,8
Technologies can take different forms such as via video conferencing, telephone, mobile phone and alert systems, and web-based
applications, all allowing easy access to and exchange of professional health advice and patient information.7,9 Telehealth can be
divided into two categories: synchronous and asynchronous. The transmission of data or patient-clinician interaction in real-time is
referred to as synchronous, while asynchronous telehealth involves receival and storage of data.10
Initially acting as a way to overcome geographical barriers, telehealth has evolved to serve many purposes, including hometelemonitoring of chronic conditions such as CF.9 As an asynchronous form of telehealth, home-telemonitoring involves the rapid
transmission of patient data from home settings to respective health facilities.11 The process requires patients or caregivers to
electronically transmit health information, allowing remote interpretation by HPs to prescribe assessments and treatments as
needed.6,10,11 As technology has advanced, so has the uptake and establishment of telehealth, encouraging more frequent and
efficient occasions of service to benefit both patients and clinicians. The integration of ICT allows the delivery of higher quality
health care through increased service availability and instant exchange of data, while having minimal disruption to patients’ daily
life and lowering costs incurred by travel.7,8,10 This upskilling of HPs also significantly benefits the health care system, allowing
maintenance of patient-clinician rapport, more effective collaboration within multi-disciplinary teams (MDTs), and potentially
reduced workloads.10
Recent evidence suggests that spirometry performed using telehealth (telespirometry) is viable for assessing paediatric and adult
CF patients for improving continuity of care, detecting pulmonary deterioration, and encouraging patient self-monitoring.5,6
Telespirometry devices usually connect to computer and record and transmit results to be accessed remotely by clinicians.6 It
allows for more frequent and closer monitoring of symptoms, triggering prompt intervention and lessening the severity of PExs or
potentially avoiding them entirely. These personal devices can also promote self-management, providing CF patients with a visual
representation of their lung function and potentially improving patient education, with the aim to increase intrinsic motivation and
self-efficacy. Furthermore, telespirometers often have attachments to additional tools such as pulse oximeters and electronic
symptom diaries and can be further enhanced by other forms of telehealth (e.g., electronic reminders and telephone or video
calling) to improve health care delivery.6,12-15
Where infection risk is high for CF populations, telespirometry may overcome these barriers by offering an alternative platform for
frequent monitoring.16 Especially in the climate of the ongoing the COVID-19 pandemic where the manifestations of the virus pose
serious danger to those with CF, telespirometry could be an ideal and suitable substitute to in-person reviews, reducing risk of
infection while providing frequent high-quality care. Due to its convenience and versatility, telespirometry can be easily used across
different contexts such as home-based admissions and outpatient monitoring.16 It can also be integrated into existing therapeutic
regimes with minimal disruption, while decreasing the burden and risk which accompany frequent hospital visits.13
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Current evidence has largely evaluated the feasibility, acceptability, and effectiveness of using general telehealth for CF
management; however, a gap in the research exists relative to analysing telespirometry in a CF-only population. Telespirometry
has the potential to support CF management, but as it is relatively new and relies on patient compliance, further research into its
performance, usability, and uptake is required. Therefore, as telehealth is a growing platform for health care, this warrants the
completion of this systematic review, which aims to summarise and evaluate the feasibility and efficacy of telespirometry to remotely
monitor children and adults with CF.
METHOD
Search Strategy
This systematic review was written with reference to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement.17 The overarching research question, “What is the feasibility and efficacy of performing telespirometry for a
CF population?” was formatted according to the Population, Intervention, Comparators, and Outcomes (PICO) structure, as
recommended by the PRISMA statement.
Population
Both adult and paediatric patients with CF were included to reflect the common use of spirometry testing over the course of a CF
patient’s lifespan.18 Spirometry technical standards and recommendations have also been developed for children and adults,
underlining its suitability for use across wide age range.19, 20
Intervention
The intervention of interest was spirometry performed via telehealth (telespirometry) as spirometry is the mostly widely used lung
function test in CF management and is useful for monitoring the course of the condition.21,22 Tests could be performed
independently or with the assistance of a HP through communication platforms such as phone call or video conferencing.
Comparators
As the feasibility and efficacy of telespirometry were being evaluated in isolation with no comparison to other assessments, no set
comparators were required to be included in this review.
Outcomes
A preliminary literature search was completed to identify common objective and subjective outcomes measures amongst the
studies which assessed the feasibility and efficacy of telespirometry for CF monitoring. These quantitative and qualitative outcomes
were then applied to the systematic review, whereby corresponding data was included for analysis and comparison.
Feasibility within this review described the practicality and capability of undertaking telespirometry assessments in a CF population.
This was measured quantitatively in terms of average patient adherence (total number of transmissions in relation to the number
of days the study was conducted over), total number of transmissions, duration taken to conduct the assessments, and proportion
of subjects requiring operational assistance.5,6,12-16,22,23-27
Efficacy was indicated by the objective success of the telespirometry tests to accurately and reliably detect PExs, initiate medical
intervention, as well as its subjective ability to improve quality of life.5,6,12-16,22,23-28
Design
A systematic review was deemed to be a suitable design at the time of writing, as no systematic reviews addressing this research
question were in the process of or had been completed. This was confirmed by searching the International Prospective Register
of Systematic Reviews (PROSPERO).
Protocol and Registration
This systematic review protocol (CRD42020209225) was registered with PROSPERO on 2nd December 2020.
Funding and supports
No financial or non-financial supports were sourced for this review.
Eligibility criteria
Eligibility criteria were based on the elements of the PICO framework and research characteristics including language and
publication status.17 Studies were included if participants (paediatric and adult) were clinically diagnosed with CF and used a
telespirometry device for assessing lung function. Additionally, the research had to be published or able to be translated into
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English and could be of any study design. Studies were excluded if they were study protocols or prototypes or non-research
studies. Research was also excluded if the intervention combined telespirometry assessments with other assessment types, due
to difficulty incurred with determining the effect of the telespirometry in isolation. Systematic reviews were also not included for
analysis but were used to hand-search for relevant literature using reference lists.
Information Sources
Health-related online databases including CINAHL, Emcare (Ovid), Medline (Ovid), PEDro, and Scopus were searched on the 30
December 2020. These databases were selected due to the availability of a wide range of well-accredited journals from fields of
allied health, medicine, nursing, and science. A search strategy was created by the primary researcher with guidance of a James
Cook University (JCU) librarian.
Hand-searching of reference lists of key studies was performed manually to identify additional relevant literature. Literature citing
was also completed to ensure complete study selection. Google Scholar was used to identify grey literature sources not yet
published in the databases on the 27th January 2021. Search phrases used were similar to those of the database searches.
Search strategy
Database searches were constructed on the basis of the PICO outline (see Table 1). Due to the recency of telehealth, no database
limits or search filters were applied. Full search strategies are outlined in the Appendix. Due to the alternate formatting of PEDro
and Scopus searches, singular Boolean phrases were used. The final search strategy was reviewed and approved by both authors
and the assisting librarian.
Table 1. Search Phrases

Data Collection and Extraction
The PRISMA statement encompassing of the inclusion and exclusion criteria was used by the authors to screen and select suitable
literature for this review (see Figure 1).17 Search records were exported into EndNote X9 to remove duplicates and store and
organise the data obtained. Titles, abstracts, and keywords were then surveyed with reference to the eligibility criteria, discarding
unsuitable studies prior to full-text analysis.
Quantitative and qualitative data of the eligible records were synthesised, extracting common outcome measures and themes
identified among the studies. Two researchers selected and reviewed each study to ensure the inclusion of all suitable and relevant
research was to be reviewed, while also minimising the risk of bias which can be heightened by individual perspectives, values,
and beliefs.
Data items were extracted into a Microsoft Excel spreadsheet, where study characteristics were collated and summarised by the
primary researcher. The tabulated data was used to inform the results and discussion and indicated future recommendations for
research and clinical practice.
Data Items
Elements of the PICO structure, thematic similarities, and Crowe Critical Appraisal Tool (CCAT) were combined to form the data
headings, subjecting the methodology to possible risk of selection and publishing bias. The intentional selection of broad data
items was used to encompass varying study designs, interventions, and outcomes, facilitating easier comparison of the studies.
Appraisal of Study Quality and Risk of Bias
Both researchers used the CCAT paired with the CCAT user guide version 1.4, to critically appraise the research and determine
the overall quality.29,30 The framework uses the systematic subheadings: introduction, research design, sampling, data collection,
ethical matters, results, and discussion to evaluate the multiple elements which contribute to the overall quality. The CCAT was
appropriate for this systematic review due to its applicability across multiple study designs collecting quantitative or qualitative data
or combination of both. The tool also consists of a numerical scoring system which allows objective and consistent comparison of
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the literature and has been noted as a valid and reliable tool for literature appraisal, assisting in the identification of potential
sources of bias.31
Potential sources of bias were also identified throughout stages of the methodology including study selection and data extraction
and integration. This in combination with the CCAT were considered when interpreting the results and providing clinical
recommendations, hence lowering the risk of publication bias. Furthermore, each researcher independently critiqued the records
before collaborating on 8 February 2021, to compare their findings and resolve discrepancies in their scoring.
RESULTS
Study Screening and Selection
A preliminary database search identified 15 relevant studies which aligned with the chosen topic and was a sufficient number to
systematically review. Data was unable to be pooled due to the heterogenic nature of the patient characteristics and outcome
measures within the research, making it unsuitable for a meta-analysis.
Database searching yielded 86 records, while handsearching on Google Scholar located an additional 11 studies. Sixty-three
records remained after duplicates were removed. The eligibility criteria were then used to screen titles, abstracts, and keywords,
excluding a further 46 records. Seventeen studies underwent full-text screening, with a further three studies excluded (see Figure
1).

Figure 1. PRISMA Flow Chart17
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Study Characteristics
Participants
Literature examined paediatric and adult clinically diagnosed CF patients, with ages ranging from 5 to 44 years-old and mean ages
lying between 10 to 30 years-old (see Table 2). Telespirometry was undertaken by exclusively children or adolescents in six
studies.5,13,16,22-24 Four studies reviewed adults, or a combination of adults and children aged over 12 years-old.6,12,15,25 The
remaining four studies did not include the participants’ ages.14,26-28 Sample sizes ranged between five and 267 participants.
Characteristically, baseline pulmonary function and clinical stability also varied, as determined by factors such as the number of
PExs, significant decreases in mean FEV1 and change in presenting symptoms. Two studies included clinically stable patients,
defined as FEV1% predicted values of more than 25%.15,25 Conversely, three studies included those who recently deteriorated, as
indicated by infectious episodes of PExs, significant decreases in FEV1 or worsening of persistent pulmonary symptoms.5,6,24
Wilkinson et al included patients who were terminally ill and awaiting lung transplantation.15
Four studies excluded those deemed as mentally unfit or incapacitated, due to subsequent impaired ability to effectively operate
the telespirometer and understand the nature and effect of the study.6,12,15,24 Other reasons for exclusion included patients with an
unavailable land line and who were clinically unstable (e.g. terminally ill, awaiting lung transplantation).12,24,25 These exclusion
criterion reflected those who typically would be unable to perform telespirometry, as the mental and/or physical impairments may
alter the validity of the results and therefore limit its use in remote assessment.
Interventions
Six studies included a single telespirometry group (see Table 2).13,14,16,22,24,27 Nine studies compared a control group - receiving
standard care, against a group conducting telespirometry.5,6,12,15,22,23,25-27 Of the nine studies, three of these ensured both groups
were homogenous for baseline characteristics.5,25,26 Four of these studies also randomised patients between groups.12,15,25,26 Two
studies used the members of the intervention group to act as their own historic controls.6,23
Magrabi et al was the only study to conduct telespirometry in a hospital setting, with the remainder being performed in home
environments with reference to a CF centre.13 Access to telephone networks or web servers was ensured for at-home patients as
this was required for remote data transmission.5,6,12,15,16,22-24,27,28 Three studies transmitted data using telephone lines.5,12,15 Murgia
et al utilised acoustic coupling over telephone calls.14 Six studies uploaded data to or transmitted data via web-based portals such
as email for interpretation.6,16,22-24,27 Three studies failed to describe the means of data transmission.14,25,26
The amount of telespirometry training varied. Four studies provided in-person training by a HP.5,6,22,23 Logie et al assisted patients
in real-time over phone or video calls.16 Two studies supplied written instructions before requiring patients to independently record
spirometry data.13,16 Sarfaraz et al set up a helpline for those patients experiencing technical difficulties.6
The frequency of telespirometry tests and data collection ranged from daily to once weekly.5,6,13,15,22-25 Four studies did not outline
the intervention frequency.14,26-28 Similarly, variation was observed in the nature and frequency of patient follow-up. Five studies
followed-up with a mandatory phone call from a HP to review and discuss the results.5,14,23,27,28 Two studies sent phone or electronic
reminders if adherence was poor.6,24
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Abbreviations: Ab – antibiotic, BADI – Beck anxiety and depression inventories, BMI – body mass index, CF – cystic fibrosis, CFQoL – cystic fibrosis quality of life, CFQ-R – cystic fibrosis questionnaire revised, CG – control group, diff – difference, esp –
especially, FEV1 – forced expiratory volume, FVC – forced vital capacity, GP – general practitioner, HP – health professional, HR
– heart rate, HRQoL – health-related quality of life, hosp – hospital, HTS – home telespirometry, IG – intervention group, IV –
intravenous, MA – mean age, MBAS – modified Borg Anxiety Scale, mins – minutes, MPR – medication possession ratio, NAD –
nil age description, PEx – pulmonary exacerbation, PFT – pulmonary function test, QoL – quality of life, Q1 – questionnaire 1
(same applies for 2 and 3), RCT – randomised controlled trial, RSS – respiratory symptom score, SaO2 – oxygen saturation, sig –
significant, TS – telespirometry, UC – usual care
RESULTS – MAIN OUTCOMES/THEMES
Feasibility
Patient Adherence
Eight studies compared the total number of transmissions to the total number of study duration days, to calculate the average
patient adherence.5,6,14,22,23-26 Adherence rates sat between 10-11% and 50-65%.5,6,14,23,25,28 Murgia et al and Murgia et al had study
samples of 30 and 28 patients respectively, noting a low average compliance of 10% to biweekly telespirometry tests when
compared to the anticipated 40%.14,28 van Horck et al defined optimal adherence as 70% of the maximum possible number of
home transmissions, concluding 54% of children as having “good” adherence. 24 Lechtzin et al recorded a decrease in patient
adherence from 50% to 19% as the frequency of weekly transmissions increased from once to twice a week. 25 Shakkottai et al
identified a slightly higher adherence (60%) with once-weekly spirometry, implying compliance to still be problematic even with
decreased testing frequency.23 Sarfaraz et al was an outlier, reporting average compliance to daily telespirometry to be 64%.6
Despite this, patient adherence in this study was still considered to be low considering researchers and technicians were
contactable as needed. Shakkottai and Nasr recorded the highest mean adherence (95%) to weekly telespirometry testing,
however the intervention group consisted of three subjects, therefore limiting the power of the study. 22
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The total number of telespirometry transmissions was also used by three studies to measure patient adherence.13,15,27 Magrabi et
al recorded 27-54 data transmissions among its five participants, who were the only patients across the literature to not perceive
the frequency as a limitation and expressed their willingness to conduct daily spirometric tests. 13 Logie et al was the only study to
measure the portion of successful telespirometry readings, that being 93%.16
In spite of adherence being objectively poor, subjects and clinicians provided positive qualitative feedback regarding
telespirometry’s usefulness and convenience.12,13,15,16 Grzincich et al found that 70% of users were happy to self-evaluate their
respiratory health and felt safer with the monitoring and increased health knowledge. 12 Meanwhile, all doctors had no difficulties
accessing the telespirometry data and raised no concerns surrounding the feasibility of the intervention. 12
Duration for Learning and Conducting Telespirometry
Time taken to learn the telespirometry protocol or to physically conduct the assessment was recorded by four studies.12,16,22,23
Three studies concluded 30 minutes or less to be sufficient to learn the procedure.12,22,23 From interviews, time taken to perform
telespirometry tests was not perceived as barrier, with all patients disagreeing with telespirometry being described as “time
consuming”.13
Level of Assistance Required
Four studies recorded the amount of assistance provided to perform telespirometry.12,13,15,16 Grzincich et al found 90% of patients
required no domiciliary assistance and 100% were able to send data with no assistance at all.12 Questionnaire responses further
supported these results, with over 80% agreeing to future telespirometry use. Magrabi et al observed patients as requiring only a
single demonstration and requiring no assistance after the initial training period. 13 Subjects also preferred the convenience of the
telehealth platform over in-person visits.15,16 Technical difficulties however were encountered in two studies, due to incompatible
operating systems or computer models, as well as intermittent internet connections with delays in audio and visual.16,25 These
barriers were significant as they may have reduced data transmissions and delayed the detection of pulmonary deterioration.
Efficacy
Pulmonary Exacerbations
The definitions and criteria used to classify a PEx varied greatly among the literature. A reduction of more than 10% in FEV1 from
previous stable baseline measures was used on its own or in combination with other factors 6,14,24,25,27,28 Four studies examined
the total or average number of PExs which were reflective of deterioration.6,22,24,25 Sarfaraz et al recorded 53 total PExs, ranging
from zero to seven PExs per patient.6 van Horck et al recorded 28 patients who had PExs.24 Two studies recorded no significant
differences in the number of PExs between the control and experimental groups.22,25
The time to the first and/or subsequent PEx was analysed by two studies.24,25 Lechtzin et al observed a significantly higher hazard
ratio of 1.45 (p=0.01) for the time to first PEx and increased risk of subsequent PExs in the telespirometry group compared to the
control.25 Despite the groups having no statistically significant differences in the number of PExs detected, the intervention did
provoke faster diagnosis of PExs The trends of home monitored FEV1% predicted scores and respiratory symptom scores (RSS)
were analysed by van Horck et al to determine the efficacy of telespirometry in predicting PExs before physically occurring.24 The
combined FEV1% predicted scores produced by telespirometry in conjunction with the RSS was able to predict PExs one to four
weeks before symptoms presented, having a sensitivity and specificity of 92.9% and 88.9% respectively. This was higher than the
control group which used the RSS alone, only showing significant increases two weeks preceding a PEx. The RSS however was
not a validated outcome measure for symptom recording, which was accounted for when interpreting the results.
Medical Intervention – Antibiotics and Hospitalisations
As antibiotics are commonly used to treat PExs, antibiotic delivery was also used to determine the efficacy of telespirometry in
detecting pulmonary decline.5,6 Bella et al identified no significant changes in antibiotic delivery rates from pre-intervention to followup.5 Sarfaraz et al on the other hand found a significant increase in the intervention group (p=0.02) in the number of oral antibiotics
courses administered in the study period, when compared to the parallel six months of the previous and following years. 6
Five studies analysed hospitalisation rates, as an outcome of respiratory deterioration.5,16,25,26,28 According to three studies, there
were no significant effects of telespirometry on inpatient hospitalisation rates between groups.5,25,26 Lechtzin et al also recorded
more than twice as many acute visits in the intervention group compared to the control (153 vs. 64), translating to increased
likelihood of acute visits in the telespirometry group (57% vs. 29%).25 Nineteen hospital admissions based on telespirometry data
were recorded by Murgia et al.28 Meanwhile Logie et al included no statistical indicators for hospitalisation rates.16
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Validity and Reliability of Telespirometer devices
Two studies identified good correlation between FEV1% predicted values measured at-home compared to those in-clinic.22,23
Shakkottai et al reported a high intra-class correlation (0.8) across all visits.23 The positive results obtained by the Spiro PD device
however were confounded by significant inconsistencies in FEF25-75% predicted values of those obtained at home versus in the
clinic.23
The telespirometers’ validity was unclear due to dependency of patient effort. This was highlighted by a respiratory laboratory
technician, who indicated that human error (such as poor technique) in unsupervised tests led to variation in the measurements’
validity.13 Logie et al recorded two failed spirometry readings from a patient due to ‘inexplicable equipment failure’, however on
further investigation and calibration testing it was suggested that human error or environmental interference was at fault. 16
Quality of life
Both participants and health clinicians responded positively to the intervention’s usefulness in three studies.12-14 Clinician
questionnaires deemed home spirometry as a valuable tool for monitoring patient deterioration and relieving the workload of staff
at CF centres.12 Wilkinson et al recorded all five participants to have perceived telespirometry as a convenient and comforting way
of maintaining contact with HPs, preferring it over telephone calls or additional clinic visits.15
Risk of Bias Across Studies
Overall, the CCAT indicated study quality was generally poor, with common weaknesses which led to potential sources of bias.
These included selection bias, random allocation, lack of blinding and attrition bias from incomplete data and loss to follow-up,
which were considered when interpreting the results.
As gauged by the CCAT, overall study quality ranged from 23-85%, averaging an overall score of 55%. Shakkottai et al was rated
the highest quality study (85% score), with the lowest scoring (23%) study being Murgia et al.23,27 Within the CCAT, the
preliminaries, introduction and results sections scored strongly with average scores or 3.14, 3.78 and 3 out of 5 respectively. Four
studies scored two or below for the preliminaries.14,22,27,28
The CCAT indicated sampling and ethical matters as the poorest scoring areas, averaging to 1.2 and 1.5/5. With the exception of
Shakkottai et al, literature received scores of two or less for sampling, 11 of which failed to outline their sampling methods.6,1214,22,23-28 The remaining three studies utilised purposive sampling.15,16,23 Five studies did not include their sample size.6,22,23,24,27
Eleven studies scored two or below for ethical matters.5,12-14,16,22,25-28 Six of which scored zero raising concerns regarding patient
safety.5,14,28-31 Half the literature documented obtaining consent from participants.6,12,13,15,23,24 While only five studies recorded
gaining ethical approval and mention of funding sources.6,15,22-24
All studies underwent non-randomised recruitment methods due to the nature of the study designs and intervention. Six of which
intentionally selected patients with reference to certain criteria.13,14,24,26-28 Two studies also recruited participants by invitation
only.6,23
Randomisation of participants between intervention and control groups occurred in five studies, minimising the effect of allocation
bias.12,15,22,25,26 Being case series, three studies did not involve allocation to intervention and control groups. 6,23,27 Two of these
used the same group of participants in the intervention group to serve as their own historic and future controls.6,23 Two studies
matched control groups to those undertaking the intervention based on demographic characteristics such as age, sex, respiratory
function and complications.5,27 Overall sequence generation was inadequately described, with three studies failing to outline their
randomisation methods.12,26,29 Lechtzin et al reported conducting a 1:1 randomisation of CF patients to the control or intervention
group.25 Only one study performed allocation concealment, involving the preparation of sealed envelopes by a third party.15
Blinding was unable to occur due to the nature of telespirometry, which increased the risk of bias among the literature. Within those
studies comparing an intervention and control group, patients performing telespirometry may have been exposed to more frequent
clinical monitoring and received more medical attention.5,6,12,15,23,25-27 This may have unintentionally altered patient effort and
responses to the study protocols, impacting patient compliance and increasing the risk of performance bias. All studies failed to
document any measures taken to blind outcome assessors when analysing the data.
Only two out of the nine studies with two patient groups provided detail regarding incomplete data or loss to follow-up.23,25 Lechtzin
et al reported five telespirometry patients and six usual care patients who were lost to follow-up and mentioned other reasons for
withdrawal which included “subject decision” or “other”, subjecting the study to risk of attrition bias.25 Overall the intervention group
had more withdrawals than the control (24% vs. 16%).25
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Table 3. CCAT Results

Abbreviations: Disc – discussion, exp – experimental, intro – introduction, obs – observational, prelim – preliminary, RCT –
randomised controlled trial, sam – sampling
DISCUSSION
Telespirometry is a useful clinical tool for remote lung function monitoring of paediatric and adult CF patients, allowing for accurate
anticipation and detection of pulmonary deterioration. Its ease of usage and short testing duration reflects its potential to replace
in-person testing, in turn being effective in prompting early medical intervention and improving quality of life. 12,13,15,16,22,23 The
translation of telespirometry into clinical practice however is not yet appropriate for all CF populations. It is limited by poor patient
adherence and lack of consistency among testing devices and thresholds/definitions for PExs, suggesting that further research is
required to increase the success of its uptake and recording accuracy. 5,6,14,23-25,27,28 Currently it is suitable for those CF sufferers
who are highly motivated and willing to abide by the telespirometry guidelines, as well as rurally and remotely located patients
whereby access to CF centres is limited.
The diversity amongst the literature’s study designs, patient demographics, methods, outcomes, and quality, was consistent with
previous systematic reviews examining telehealth usage for CF and other chronic respiratory conditions.4,11,32 The majority of
studies in this review were small, observational trials which were subject to high risk of biases and had limited external validity,
restricting their generalisability to the broader CF population. With respect to age, studies commonly included younger participants
up to 44 years old, reflecting the average CF population with a prognosis of 46.33
The differences in disease severity and baseline lung function raised uncertainties when evaluating and comparing studies’ internal
validity. Depending on their baseline, patients may have been more susceptible to PExs and thus increasing the sensitivity of the
telespirometry to detecting deterioration. Inconsistency in the study protocols and outcome measures also limited the comparability
of the results and the confidence of clinical recommendations made. Other systematic reviews also assessing the use of telehealth
for chronic disease management were met with similar barriers within their methodologies.32
The key findings revealed that despite telespirometry being theoretically feasible and effective, further investigation is required to
have widespread clinical use. Ongoing research focusing on strategies to improve patient adherence and detection of pulmonary
decline are imperative prior to the substitution of in-hospital assessments with at-home telespirometry. Current feedback is
promising and is in keeping with previous studies which have noted positive patient and family responses to telehealth use.34 CF
patients and their families typically burdened with extensive regimes, were able to acknowledge the usefulness and convenience
of telespirometry.12,13,15,16 As highlighted by Logie et al, particularly those with difficulty accessing their major CF centres frequently,
valued the reduction of expenses associated with transport, accommodation and lost income, not dissimilar to previous studies
which utilised telehealth in regional, rural and remote settings.16,35
Despite these perceived advantages paired with successful data transmissions, patient adherence across all ages was poor. This
potentially indicated that the addition of telespirometry to their regime needs to be modified to prevent patients from being
© The Internet Journal of Allied Health Sciences and Practice, 2022

FEASIBILITY AND EFFICACY OF TELESPIROMETRY FOR PULMONARY MONITORING

12

overwhelmed.5,6,14,23-26,28 This was observed even in studies whereby minimal time was needed to effectively operate the systems
and support was offered, which was reinforced by patients reporting the telespirometry process as too burdensome or
extreme.6,12,25 This trend was similarly observed in previous literature which noted decreased patient adherence with higher
frequency of transmissions or increased monitoring.11 The literature therefore implies that although being feasible, telespirometry
may still be too complex or frequent for CF patients, compared to their usual regime and hence not yet practical for full
implementation.
To increase patient compliance, more realistic approaches to telespirometry include adjusting the frequency of data transmissions.
Decreasing the regularity of telespirometry tests, is likely to be perceived as less onerous and hence have better uptake. For
paediatric CF patients, incentivised telespirometry tests may also improve adherence, through use of a game-type interface or
increased visual aids.13 This would provide simpler testing targets for patients, improving their technique and strengthening the
accuracy and validity of the readings. Further qualitative data would also be valuable to highlight barriers to its successful
implementation and obtain patients’ recommendations on how to improve the intervention.
This review used several outcomes to determine the efficacy of telespirometry, however it was found that those directly related to
the PExs themselves were most useful. These included the number of PExs detected and how early these were identified before
symptoms presented. These outcomes were of particular importance as they provided the basis for instigating ongoing
interventions such as antibiotic administering and hospitalisation and therefore should be used consistently in future research to
evaluate telespirometry testing. Within this systematic review establishing efficacy was unfortunately complicated by
inconsistencies in what constituted a PEx, with criteria being based on patients’ symptoms, telespirometry readings or
both.6,27,28,30,31 The limited comparability between studies therefore weakened the evidence and systematic review and should be
addressed in ongoing research to ensure more definite conclusions can be drawn.
Lack of standardisation in the set-up, calibration and utilisation of the telespirometry interventions also diminished comparison of
studies and obstructed evaluation of the tool’s efficacy. Validation of the telespirometer devices and reporting of the accuracy and
reliability of the readings relative to in-clinic results was poor among the studies. Validity of the obtained results was also
questionable, due to their variance depending on human effort.13,16 The high rates of non-compliance in combination with small
sample sizes also blurred the determination of overall efficacy due to lack of sufficient data for analysis.
Limitations
Research as indicated by the CCAT was generally poor and highlighted common weaknesses in sampling methods and ethics.
Study samples tended to be small and carefully selected, potentially reducing their ability to detect a true effect and increasing the
possibility of detecting false negatives. Moreover, the specificity of the samples also undermined the external validity of the results.
Patients were also at risk of performance bias as they were unable to be blinded, suggesting that results may have been skewed
by behavioural influences and not directly a product of the intervention alone. This unavoidable consciousness of their assigned
treatment may have also affected patients’ perceptions and responses to the treatment and as a result impacted patient compliance
which was largely poor. The poor compliance, as seen by the less than expected total transmissions, resulted in insufficient
amounts of data to be analysed, posing further challenges to establishing the efficacy of telespirometry.
The inconsistency in defining a PEx, stemming from the absence of universal CF-specific PEx criteria, was an additionally identified
limitation. Varying combinations of signs, symptoms, patient scores and/or spirometry results were used to classify PExs, creating
inequalities as to which patients required further medical intervention. A potential classification of a PEx could be based on those
criteria for chronic obstructive pulmonary disease (COPD), which categorises PExs by type and includes a minimum number of
presenting symptoms such as sputum volume and purulence, dyspnoea, cough severity and frequency.36
Additionally, telespirometer device models across the literature differed, therefore varying in calibration and validation protocols
which decreased studies’ comparability and the reliability and efficacy of the tool. Procedures also varied in the amount and nature
of instruction given. Together these inconsistencies and absence of a universal protocol for telespirometry made it difficult to
establish the efficacy of telespirometry, diminishing the certainty in recommending its broader use for CF management.
Implications for Future Research and Clinical Practice
This systematic review has shown the potential for telespirometry to monitor CF patients remotely. The majority of participants
have described it as easy to setup and conduct with or without the assistance of HPs and identified it as a convenient and feasible
alternative for lung function monitoring. In spite of these positive results, the literature highlighted inconsistencies among research
methods which may have decreased adherence and clinical efficacy. Telespirometry for CF patients would therefore benefit from
more extensive research to ensure successful implementation in a clinical context.
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To be more robust, future research should aim to be multi-centred, have larger samples and occur over longer durations to reflect
the chronicity of CF and allow better generalisability of results. Studies would also benefit from broader inclusion criteria to
accommodate for a wider range of CF patients who vary in age and disease severity. Furthermore, as current studies are largely
observational, completion of more experimental trials would strengthen these findings. Studies should also consider using and
clearly documenting randomised allocation methods to reduce the risk of selection bias.
To improve the studies’ validity, telespirometers should be calibrated against certified recommendations, such as those outlined
by the American Thoracic Society.18 This standardisation would also increase the accuracy of the readings to better detect PExs,
while allowing better comparison of the literature, as outcomes would have less variation with consistent interventions.
Unlike other chronic conditions such as COPD, CF lacks uniform signs and symptoms which classify a PEx. In turn, studies varied
in their sensitivity to detecting pulmonary decline, making it hard to determine the efficacy of telespirometry. With standardised
criteria, more consistent and potentially earlier detection of PExs would occur, prompting therapeutic intervention and preventing
unnecessary hospitalisations.
Although telespirometry has been recognised as being feasible for CF monitoring, it may be more suited to highly motivated patients
willing to incorporate this testing into their current regime or who have frequent access to supports to ensure good compliance. It
is also a more convenient and feasible option for those patients unable to attend regular clinic consults such as individuals and
families living rurally/remotely. A positive shift in the uptake of and attitude towards telehealth for CF management has also been
observed following the recent COVID-19 pandemic.38 Remote monitoring typically seen as an additional service is now being
utilised as a replacement for face-to-face interactions. Its widespread use showcases a promising new mode of chronic health care
which reduces risk of infection, particularly for vulnerable populations, and extends well beyond this pandemic period.38
CONCLUSION
This systematic review aimed to summarise and evaluate the feasibility and efficacy of telespirometry assessments to monitor
pulmonary function for CF patients. With the inclusion of quantitative and qualitative data, strengths and gaps in the current
evidence base were identified, warranting the need for further research to enhance its incorporation into regular clinical practice.
Overall, the literature has revealed telespirometry as a promising tool, which was well received by patients and their families. CF
users were able to appreciate its convenience and navigate the systems and devices with ease. With evidence showing no clear
clinical efficacy, compounded with the complexity of CF and inconsistencies in defining a PEx, future research with standardised
telespirometry protocols and criteria for deterioration is warranted before it can be regularly incorporated to replace in-person
assessments. These modifications are essential to improving the validity of the readings and to clarify its ability to prompt earlier
therapeutic intervention and prevent hospitalisation. As patient compliance was poor throughout, studies should also aim to adjust
elements of the assessment regime such as transmission frequency or electronic reminders to increase patient uptake.
This systematic review suggests that telespirometry is feasible for use by specific CF patient groups, to supplement in-person
spirometry testing. Those most suited to use the technology include those who do not reside in metropolitan areas and
subsequently infrequently access specialist care, in addition to motivated individuals willing to independently adhere to the regime.
With more definite research, telespirometry can be utilised effectively to increase continuity of care and in turn improve patient
outcomes and QoL.
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APPENDIX
Appendix 1: Search Syntax
CINAHL search one
“cystic fibrosis”
AND
“mobile health” OR telehealth OR telemedicine OR telemonitoring OR ehealth OR mhealth
AND
spirometry OR spirometer OR pulmonary function test OR lung function test OR respiratory function test OR lung volume
measurements
CINAHL modified search
“cystic fibrosis”
AND
“mobile health” OR telehealth OR telemedicine OR telemonitoring OR ehealth OR mhealth
AND
Spirometry OR respiratory function test+
Emcare (Ovid) search
“cystic fibrosis”
AND
“mobile health” OR telehealth OR telemedicine OR telemonitoring OR ehealth OR mhealth
AND
spirometry (subject heading, search as keyword) OR spirometer (search as keyword) OR lung function test* (search as keyword)
*the scope function was used to confirm that lung function test was inclusive of:
• function test, lung
• respiratory function tests
• function test, pulmonary
• respiratory test
• pulmonary function test
• ventilation test
• respiratory function test
Medline (Ovid) search
“cystic fibrosis”
AND
“mobile health” OR telehealth OR telemedicine OR telemonitoring OR ehealth OR mhealth
AND
Spirometry (no subject headings chosen) OR spirometer (include all subheadings) OR pulmonary function test OR lung function
test OR respiratory function test OR lung volume measurements
PEDRo search phrases
The search terms were combined to form a singular Boolean phrase however no results were found. The following two phrases
were used instead:
• "cystic fibrosis" spiromet* (yielded 29 records, none were of relevance)
• "cystic fibrosis" "telehealth" (yielded 0 records)
Scopus search
( TITLE-ABS-KEY ( "cystic fibrosis" ) AND TITLE-ABS-KEY ( spiromet* OR "pulmonary function test" OR "lung function
test" OR "respiratory function test" OR "lung volume measurement" ) AND TITLE-ABS-KEY ( "mobile
health" OR telehealth OR telemedicine OR telemonitoring OR ehealth OR mhealth ) )
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Appendix 2: PRISMA Checklist

From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an
updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71
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